Candesartan

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Candesartan and local guidelines before prescribing.

Angiotensin II receptor blocker

Mechanism

Angiotensin II type 1 receptor blocker.

Uses

Hypertension, heart failure with reduced EF.

Dosing

Side effects

Dizziness, hyperkalaemia, renal impairment, hypotension; angioedema rare.

Interactions

NSAIDs, potassium-sparing diuretics and ACE inhibitors increase renal and potassium risk; lithium levels rise.

Contraindications and cautions

Pregnancy, bilateral renal artery stenosis, hyperkalaemia

Monitoring

U&E at 1–2 weeks

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Reduce start dose in renal or hepatic impairment

Overdose and reversal

Supportive; fluids and pressors for hypotension

Special advice

Check U&E 1 to 2 weeks after starting or increasing; avoid in pregnancy and bilateral renal artery stenosis.

More from the textbook: uses, cautions and other points
Where it is discussed in the book